元の
With a rarity of 1:500,000 people worldwide, there's no direct life expectancy of someone with Factor VII Deficiency. All bleeding disorders, be it mild, moderate or severe, all react differently in patients. A patient with severe FVIId may rarely bleed, or never have the need for NovoSeven - whereas a patient with mild FVIId may experience muscle and joint bleeds on a regular basis, or require the need for more frequent NovoSeven shots.